MannKind Corporation
| Type | Public |
|---|---|
| Nasdaq: MNKD Russell 2000 Component | |
| Industry | Biotechnology |
| Founded | 1991 |
| Founder | Alfred E. Mann |
| Headquarters | , U.S. |
| Key people | Kent Kresa (chairman) Dr. Michael E. Castagna (CEO) |
| Revenue | |
| Total assets | |
| Total equity | |
Number of employees | |
| Website | mannkindcorp |
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann.